Insulin-dependent Diabetes Mellitus: Clinical Trials

7 trials for Insulin-dependent Diabetes Mellitus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 unknown. 3 Not applicable, 2 Phase 2, 1 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 3
Phase 22Completed 2
Phase 11Completed 1
Phase 41Unknown 1

Follow Insulin-dependent Diabetes Mellitus: new trials by email Literature Review of Insulin-dependent Diabetes Mellitus trials Research Report on Insulin-dependent Diabetes Mellitus

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
DreaMed Advisor Pro System in Subjects With Type 1 Diabetes Treated With MDI Therapy
Advisor Pro - Insulin-dependent Diabetes Mellitus, Diabetes Mellitus, Type 1
Not applicableCompletedDreaMed Diabetes352019-11-272021-08-17
Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D
PRAM9, Regular Insulin + Pramlintide, Regular Insulin - Diabetes Mellitus, Type 1, Insulin-dependent Diabetes Mellitus
Phase 2CompletedXeris Pharmaceuticals182019-08-222024-03-27
Information and Communication Technology Based Centralized Clinical Trial Monitoring System for Insulin Dose Adjustment
Algorithm-based feedback messages, Personal Health Record - Diabetes Mellitus, Insulin Hypoglycemia
Not applicableCompletedSamsung Medical Center1122017-09-262019-04-05
Switching From Insulin to Sulfonylurea in Diabetes Associated With Variants in MODY Genes
Sulfonylurea - Maturity-Onset Diabetes of the Young, Type 3, Maturity Onset Diabetes of the Young, Type 1
Phase 4UnknownHaukeland University Hospital302017-04-182020-01-27
Evaluation of a Diabetes Vaccine in Newly Diagnosed Diabetics
IBC-VS01, IBC-VS01 placebo - Insulin-dependent Diabetes Mellitus, Diabetes Mellitus
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)122003-03-012017-02-08
Interferon-Alpha for Diabetes Mellitus Type 1
30,000 units hrINF-alpha, 5,000 hrINF-alpha, Placebo - Insulin-Dependent Diabetes Mellitus
Phase 2CompletedThe University of Texas Health Science Center, Houston572001-09-012013-11-19
African-American Diabetes Intervention Project
home based worker - Insulin-Dependent Diabetes Mellitus
Not applicableCompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2010-02-15

Narrower conditions

Diabetes Mellitus, Type 1 (7)  ·  Diabetes Mellitus (3)  ·  Insulin Resistance (1)  ·  Maturity-Onset Diabetes of the Young, Type 1 (1)  ·  Maturity-Onset Diabetes of the Young, Type 3 (1)

Broader conditions

Autoimmune Diseases (7)  ·  Endocrine System Diseases (7)  ·  Glucose Metabolism Disorders (7)  ·  Immune System Diseases (7)  ·  Metabolic Diseases (7)  ·  Nutritional and Metabolic Diseases (7)  ·  Diabetes Mellitus (4)  ·  Hyperinsulinism (1)

Interventions

Glipizide (1)  ·  Glyburide (1)  ·  Health Records, Personal (1)  ·  Insulin (1)  ·  Sulfonylurea Compounds (1)  ·  pramlintide (1)

Sponsors

DreaMed Diabetes (1)  ·  Haukeland University Hospital (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  Samsung Medical Center (1)  ·  The University of Texas Health Science Center, Houston (1)  ·  Xeris Pharmaceuticals (1)

Countries

United States (4)  ·  Israel (1)  ·  Norway (1)  ·  South Korea (1)

Top investigators

Andrea Valasquez (1)  ·  George Atiee (1)  ·  Kristina I Rother, M.D. (1)  ·  Sang-Man Jin, MD PhD (1)  ·  Staley A Brod, MD (1)  ·  Tihamer Orban, MD (1)  ·  Yael Shtrit (1)

Results publications

PMID 19564474, PMID 19931408, PMID 28720103, PMID 37798422